Raymond James & Associates Lemaitre Vascular Inc Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

A detailed history of Raymond James & Associates transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Raymond James & Associates holds 29,592 shares of LMAT stock, worth $3.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,592
Previous 28,844 2.59%
Holding current value
$3.12 Million
Previous $2.37 Million 15.8%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$80.3 - $92.89 $60,064 - $69,481
748 Added 2.59%
29,592 $2.75 Million
Q2 2024

Jul 19, 2024
SELL
$62.62 - $83.59 $39,888 - $53,246
-637 Reduced 2.16%
28,844 $2.37 Million
Q1 2024

Apr 22, 2024
BUY
$54.0 - $71.06 $73,224 - $96,357
1,356 Added 4.82%
29,481 $1.96 Million
Q4 2023

Jan 16, 2024
BUY
$45.37 - $58.41 $149,630 - $192,636
3,298 Added 13.28%
28,125 $1.6 Million
Q3 2023

Oct 24, 2023
BUY
$53.45 - $67.01 $51,686 - $64,798
967 Added 4.05%
24,827 $1.35 Million
Q2 2023

Jul 25, 2023
BUY
$50.38 - $68.21 $140,006 - $189,555
2,779 Added 13.18%
23,860 $1.61 Million
Q1 2023

Apr 14, 2023
BUY
$44.73 - $51.68 $68,839 - $79,535
1,539 Added 7.88%
21,081 $1.09 Million
Q4 2022

Feb 08, 2023
BUY
$41.94 - $52.25 $146,328 - $182,300
3,489 Added 21.73%
19,542 $899,000
Q3 2022

Oct 25, 2022
BUY
$45.29 - $55.99 $69,882 - $86,392
1,543 Added 10.63%
16,053 $814,000
Q2 2022

Aug 12, 2022
BUY
$39.05 - $47.85 $69,313 - $84,933
1,775 Added 13.94%
14,510 $661,000
Q1 2022

May 11, 2022
SELL
$40.48 - $51.5 $69,666 - $88,631
-1,721 Reduced 11.91%
12,735 $592,000
Q4 2021

Feb 08, 2022
BUY
$46.66 - $56.25 $183,560 - $221,287
3,934 Added 37.39%
14,456 $726,000
Q3 2021

Nov 02, 2021
BUY
$53.09 - $60.57 $36,419 - $41,551
686 Added 6.97%
10,522 $559,000
Q2 2021

Aug 11, 2021
BUY
$47.74 - $63.33 $88,748 - $117,730
1,859 Added 23.3%
9,836 $600,000
Q1 2021

May 14, 2021
BUY
$40.19 - $51.5 $320,595 - $410,815
7,977 New
7,977 $389,000
Q4 2020

Feb 12, 2021
SELL
$31.44 - $41.27 $1.23 Million - $1.62 Million
-39,173 Closed
0 $0
Q3 2020

Nov 04, 2020
SELL
$25.73 - $33.98 $36,305 - $47,945
-1,411 Reduced 3.48%
39,173 $1.27 Million
Q2 2020

Jul 28, 2020
SELL
$22.88 - $30.71 $8,671 - $11,639
-379 Reduced 0.93%
40,584 $1.07 Million
Q1 2020

Apr 21, 2020
SELL
$21.03 - $38.46 $399,717 - $731,009
-19,007 Reduced 31.69%
40,963 $1.02 Million
Q4 2019

Feb 12, 2020
BUY
$31.27 - $36.21 $981,190 - $1.14 Million
31,378 Added 109.74%
59,970 $2.16 Million
Q3 2019

Nov 07, 2019
SELL
$27.91 - $35.78 $14,541 - $18,641
-521 Reduced 1.79%
28,592 $977,000
Q2 2019

Aug 06, 2019
BUY
$25.55 - $30.79 $42,438 - $51,142
1,661 Added 6.05%
29,113 $815,000
Q1 2019

May 06, 2019
SELL
$22.45 - $31.55 $987 - $1,388
-44 Reduced 0.16%
27,452 $851,000
Q4 2018

Feb 11, 2019
BUY
$22.01 - $37.23 $48,444 - $81,943
2,201 Added 8.7%
27,496 $650,000
Q3 2018

Nov 14, 2018
BUY
$34.02 - $38.74 $170,440 - $194,087
5,010 Added 24.7%
25,295 $980,000
Q2 2018

Aug 14, 2018
BUY
$31.45 - $41.02 $637,963 - $832,090
20,285 New
20,285 $679,000
Q4 2017

Feb 14, 2018
SELL
$30.9 - $39.01 $165,685 - $209,171
-5,362 Closed
0 $0
Q3 2017

Nov 13, 2017
SELL
$32.75 - $39.13 $131,786 - $157,459
-4,024 Reduced 42.87%
5,362 $201,000
Q2 2017

Aug 14, 2017
BUY
N/A
9,386
9,386 $293,000

Others Institutions Holding LMAT

# of Institutions
292
Shares Held
20.5M
Call Options Held
5.2K
Put Options Held
2.9K
View Full List

About LEMAITRE VASCULAR INC

LMAT Quotes by TradingView
  • Ticker LMAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 21,962,900
  • Market Cap $2.32B
  • Description
  • LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...
More about LMAT
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email